J
Juergen Behr
Researcher at Ludwig Maximilian University of Munich
Publications - 230
Citations - 18254
Juergen Behr is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Pulmonary hypertension. The author has an hindex of 45, co-authored 198 publications receiving 14937 citations. Previous affiliations of Juergen Behr include Ruhr University Bochum.
Papers
More filters
Journal ArticleDOI
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu,Harold R. Collard,Jim J. Egan,Fernando J. Martinez,Juergen Behr,Kevin K. Brown,Thomas V. Colby,Jean-François Cordier,Kevin R. Flaherty,Joseph A. Lasky,David A. Lynch,Jay H. Ryu,Jeffrey J. Swigris,Athol U. Wells,Julio Ancochea,Demosthenes Bouros,Carlos Roberto Ribeiro de Carvalho,Ulrich Costabel,Masahito Ebina,David M. Hansell,Takeshi Johkoh,Dong Soon Kim,Talmadge E. King,Yasuhiro Kondoh,Jeffrey L. Myers,Nestor L. Müller,Andrew G. Nicholson,Luca Richeldi,Moisés Selman,Rosalind F. Dudden,Barbara S. Griss,Shandra Protzko,Holger J. Schünemann +32 more
TL;DR: This document represents the current state of knowledge regarding idiopathic pulmonary fibrosis, and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course.
Journal ArticleDOI
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu,Martine Remy-Jardin,Jeffrey L. Myers,Luca Richeldi,Christopher J. Ryerson,David J. Lederer,Juergen Behr,Vincent Cottin,Sonye K. Danoff,Ferran Morell,Kevin R. Flaherty,Athol U. Wells,Fernando J. Martinez,Arata Azuma,Thomas Bice,Demosthenes Bouros,Kevin K. Brown,Harold R. Collard,Abhijit Duggal,Liam Galvin,Yoshikazu Inoue,R. Gisli Jenkins,Takeshi Johkoh,Ella A. Kazerooni,Masanori Kitaichi,Shandra L Knight,George Mansour,Andrew G. Nicholson,Sudhakar Pipavath,Ivette Buendía-Roldán,Moisés Selman,William D. Travis,Simon L.F. Walsh,Kevin C. Wilson +33 more
TL;DR: The guideline panel provided recommendations related to the diagnosis of IPF, including a conditional recommendation for multidisciplinary discussion and a strong recommendation against measurement of serum biomarkers for the sole purpose of distinguishing IPF from other ILDs.
Journal ArticleDOI
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu,Bram Rochwerg,Yuan Zhang,Carlos A. Cuello Garcia,Arata Azuma,Juergen Behr,Jan Brozek,Harold R. Collard,William Cunningham,Sakae Homma,Takeshi Johkoh,Fernando J. Martinez,Jeffrey L. Myers,Shandra Protzko,Luca Richeldi,David Rind,Moisés Selman,Arthur C. Theodore,Athol U. Wells,Henk C. Hoogsteden,Holger J. Schünemann +20 more
TL;DR: In this article, the authors updated the American Thoracic Society/European Respiratory Society/Japanese Rensenshine Society/Latin American thoracic Association guideline on idiopathic pulmonary fibrosis treatment using systematic reviews and meta-analyses.
Journal ArticleDOI
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Maurits Demedts,Juergen Behr,Roland Buhl,Ulrich Costabel,Richard Dekhuijzen,Henk M. Jansen,William MacNee,Michiel Thomeer,Benoit Wallaert,François Laurent,Andrew G. Nicholson,Eric Verbeken,Johny Verschakelen,Christopher D.R. Flower,Frédérique Capron,Stefano Petruzzelli,Paul De Vuyst,Jules M.M. van den Bosch,Eulogio Rodriguez-Becerra,Giuseppina Corvasce,Ida Lankhorst,Marco Sardina,Mauro Montanari +22 more
TL;DR: Therapy with acetylcysteine at a dose of 600 mg three times daily, added to prednisone and azathioprine, preserves vital capacity and DL(CO) in patients with idiopathic pulmonary fibrosis better than does standard therapy alone.
Journal ArticleDOI
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
Harold R. Collard,Christopher J. Ryerson,Tamera J. Corte,Gisli Jenkins,Y. Kondoh,David J. Lederer,Joyce S. Lee,Toby M. Maher,Athol U. Wells,Katerina M. Antoniou,Juergen Behr,Kevin K. Brown,Cottin,K. R. Flaherty,Junya Fukuoka,David M. Hansell,Takeshi Johkoh,Naftali Kaminski,Dong Soon Kim,Martin Kolb,David A. Lynch,J.L. Myers,Ganesh Raghu,Luca Richeldi,Hiroyuki Taniguchi,Fernando J. Martinez +25 more
TL;DR: To better reflect the current state of knowledge and improve the feasibility of future research into its etiology and treatment, the working group proposes a new conceptual framework for acute respiratory deterioration in idiopathic pulmonary fibrosis and a revised definition and diagnostic criteria for acute exacerbation.